BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 32079024)

  • 1. Interruption of continuous opioid exposure exacerbates drug-evoked adaptations in the mesolimbic dopamine system.
    Lefevre EM; Pisansky MT; Toddes C; Baruffaldi F; Pravetoni M; Tian L; Kono TJY; Rothwell PE
    Neuropsychopharmacology; 2020 Oct; 45(11):1781-1792. PubMed ID: 32079024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential Patterns of Synaptic Plasticity in the Nucleus Accumbens Caused by Continuous and Interrupted Morphine Exposure.
    Lefevre EM; Gauthier EA; Bystrom LL; Scheunemann J; Rothwell PE
    J Neurosci; 2023 Jan; 43(2):308-318. PubMed ID: 36396404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroligin-3 in dopaminergic circuits promotes behavioural and neurobiological adaptations to chronic morphine exposure.
    Brandner DD; Retzlaff CL; Kocharian A; Stieve BJ; Mashal MA; Mermelstein PG; Rothwell PE
    Addict Biol; 2023 Jan; 28(1):e13247. PubMed ID: 36577719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential patterns of basal and naloxone-evoked dopamine efflux in the rat dorsal and ventral striatum following prolonged-intermittent exposure to morphine.
    Ahn S; Zou H; Seamans JK; Phillips AG
    Eur J Neurosci; 2024 Mar; 59(6):1067-1078. PubMed ID: 37985418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A single exposure to morphine induces long-lasting behavioural and neurochemical sensitization in rats.
    Vanderschuren LJ; De Vries TJ; Wardeh G; Hogenboom FA; Schoffelmeer AN
    Eur J Neurosci; 2001 Nov; 14(9):1533-8. PubMed ID: 11722615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morphine-induced analgesic tolerance, locomotor sensitization and physical dependence do not require modification of mu opioid receptor, cdk5 and adenylate cyclase activity.
    Contet C; Filliol D; Matifas A; Kieffer BL
    Neuropharmacology; 2008 Mar; 54(3):475-86. PubMed ID: 18082850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic and intermittent morphine treatment differently regulates opioid and dopamine systems: a role in locomotor sensitization.
    Le Marec T; Marie-Claire C; Noble F; Marie N
    Psychopharmacology (Berl); 2011 Jul; 216(2):297-303. PubMed ID: 21340469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of serotonin 5-HT(2C) receptor suppresses behavioral sensitization and naloxone-precipitated withdrawal symptoms in morphine-dependent mice.
    Zhang G; Wu X; Zhang YM; Liu H; Jiang Q; Pang G; Tao X; Dong L; Stackman RW
    Neuropharmacology; 2016 Feb; 101():246-54. PubMed ID: 26432939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 18-MC acts in the medial habenula and interpeduncular nucleus to attenuate dopamine sensitization to morphine in the nucleus accumbens.
    Taraschenko OD; Shulan JM; Maisonneuve IM; Glick SD
    Synapse; 2007 Jul; 61(7):547-60. PubMed ID: 17447255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ghrelin receptor antagonism of morphine-induced conditioned place preference and behavioral and accumbens dopaminergic sensitization in rats.
    Jerabek P; Havlickova T; Puskina N; Charalambous C; Lapka M; Kacer P; Sustkova-Fiserova M
    Neurochem Int; 2017 Nov; 110():101-113. PubMed ID: 28958601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presynaptic dopaminergic function in the nucleus accumbens following chronic opiate treatment and precipitated withdrawal.
    Ghosh S; Grasing K
    Neurochem Res; 1999 Jan; 24(1):95-107. PubMed ID: 9973242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morphine acutely and persistently attenuates nonvesicular GABA release in rat nucleus accumbens.
    Schoffelmeer AN; Wardeh G; Vanderschuren LJ
    Synapse; 2001 Nov; 42(2):87-94. PubMed ID: 11574945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine D3 receptor-regulated NR2B subunits of N-methyl-d-aspartate receptors in the nucleus accumbens involves in morphine-induced locomotor activity.
    Liu XS; Hou Y; Yan TL; Guo YY; Han W; Guan FL; Chen T; Li T
    CNS Neurosci Ther; 2014 Sep; 20(9):823-9. PubMed ID: 24797707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of oxytocin in the neuroadaptation to drugs of abuse.
    Sarnyai Z; Kovács GL
    Psychoneuroendocrinology; 1994; 19(1):85-117. PubMed ID: 9210215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preclinical evidence for the use of the atypical antipsychotic, brexpiprazole, for opioid use disorder.
    Nickols JER; Dursun SM; Taylor AMW
    Neuropharmacology; 2023 Aug; 233():109546. PubMed ID: 37068603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of repeated administration of morphine, cocaine and ethanol on mu and delta opioid receptor density in the nucleus accumbens and striatum of the rat.
    Turchan J; Przewłocka B; Toth G; Lasoń W; Borsodi A; Przewłocki R
    Neuroscience; 1999; 91(3):971-7. PubMed ID: 10391475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The γ-aminobutyric acid type B (GABAB) receptor agonist baclofen inhibits morphine sensitization by decreasing the dopamine level in rat nucleus accumbens.
    Fu Z; Yang H; Xiao Y; Zhao G; Huang H
    Behav Brain Funct; 2012 Jul; 8():20. PubMed ID: 22559224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-administration of dextromethorphan with morphine attenuates morphine rewarding effect and related dopamine releases at the nucleus accumbens.
    Huang EY; Liu TC; Tao PL
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Nov; 368(5):386-92. PubMed ID: 14564449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aquaporin-4 deletion attenuates opioid-induced addictive behaviours associated with dopamine levels in nucleus accumbens.
    Lv Y; Jing MY; Li PY; Zhao TY; Pang C; Lu GY; Wang ZY; Wu N; Hu G; Song R; Li J
    Neuropharmacology; 2022 May; 208():108986. PubMed ID: 35134442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term opiate effects on amphetamine-induced dopamine release in the nucleus accumbens core and conditioned place preference.
    He S; Li N; Grasing K
    Pharmacol Biochem Behav; 2004 Feb; 77(2):327-35. PubMed ID: 14751461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.